当前位置:首页 - 行情中心 - 三诺生物(300298) - 财务分析 - 现金流量表

三诺生物

(300298)

  

流通市值:72.35亿  总市值:89.93亿
流通股本:4.48亿   总股本:5.57亿

现金流量表

报告期2026-06-302026-03-312025-12-312025-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金2,535,440,506.831,203,883,454.764,972,518,406.693,640,108,982.04
  收到的税费返还19,897,119.3610,176,373.5737,459,740.7436,665,596.87
  收到其他与经营活动有关的现金17,526,723.3510,217,871.5364,349,868.0441,995,812.46
  经营活动现金流入小计2,572,864,349.541,224,277,699.865,074,328,015.473,718,770,391.37
  购买商品、接受劳务支付的现金877,904,287.66470,465,838.631,889,558,168.671,254,446,571.76
  支付给职工以及为职工支付的现金651,406,523.24358,767,043.251,212,570,383.93919,419,480.46
  支付的各项税费185,768,871.3773,123,402.55306,526,118.8208,583,504.18
  支付其他与经营活动有关的现金620,294,953.88276,027,125.081,060,528,775.49799,091,861.31
  经营活动现金流出小计2,335,374,636.151,178,383,409.514,469,183,446.893,181,541,417.71
  经营活动产生的现金流量净额237,489,713.3945,894,290.35605,144,568.58537,228,973.66
二、投资活动产生的现金流量:
  收回投资收到的现金--34,452,466.0234,452,466.02
  取得投资收益收到的现金832,536.93832,536.931,580,438.221,154,018.21
  处置固定资产、无形资产和其他长期资产收回的现金净额408,130.6456,363.286,858.754,649.6
  收到的其他与投资活动有关的现金142,482,266.71105,080,067.951,241,291,973.12929,194,855.15
  投资活动现金流入小计143,722,934.28105,968,968.081,277,411,736.06964,855,988.98
  购建固定资产、无形资产和其他长期资产支付的现金72,655,001.7538,764,904.66198,871,579.45155,758,536.5
  投资支付的现金3,497,6833,297,683--
  取得子公司及其他营业单位支付的现金---122,967.08-
  支付其他与投资活动有关的现金162,776,478.6650,000,0001,372,554,877.351,082,815,470.03
  投资活动现金流出小计238,929,163.4192,062,587.661,571,303,489.721,238,574,006.53
  投资活动产生的现金流量净额-95,206,229.1313,906,380.42-293,891,753.66-273,718,017.55
三、筹资活动产生的现金流量:
  取得借款收到的现金231,341,934.9181,002,288.92421,740,381.86288,150,542.75
  收到其他与筹资活动有关的现金--1,089,811.72-
  筹资活动现金流入小计231,341,934.9181,002,288.92422,830,193.58288,150,542.75
  偿还债务支付的现金137,252,330.66113,283,133.48442,567,639.2292,770,692.47
  分配股利、利润或偿付利息支付的现金3,100,931.321,181,706.19136,787,579.63125,138,472.5
  其中:子公司支付给少数股东的股利、利润--1,679,238.19-
  支付其他与筹资活动有关的现金232,780,014.25102,032,170.11219,185,675.82140,277,183.11
  筹资活动现金流出小计373,133,276.23216,497,009.78798,540,894.65558,186,348.08
  筹资活动产生的现金流量净额-141,791,341.32-135,494,720.86-375,710,701.07-270,035,805.33
四、汇率变动对现金及现金等价物的影响-19,938,479.14-8,270,355.53-7,126,733.52-1,918,721.91
五、现金及现金等价物净增加额-19,446,336.2-83,964,405.62-71,584,619.67-8,443,571.13
  加:期初现金及现金等价物余额770,878,838.55770,870,272.55842,454,892.22842,454,892.22
  期末现金及现金等价物余额751,432,502.35686,905,866.93770,870,272.55834,011,321.09
补充资料:
  净利润226,680,605.13-22,076,674.05-
  资产减值准备7,162,193.8-195,074,989.94-
  固定资产和投资性房地产折旧60,912,717.24-142,387,334.51-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧60,912,717.24-142,387,334.51-
  无形资产摊销11,721,001.63-39,286,500.11-
  长期待摊费用摊销1,747,923.85-5,524,808.79-
  处置固定资产、无形资产和其他长期资产的损失-292,657.07-1,143,532.66-
  固定资产报废损失34,631.52---
  公允价值变动损失-1,440,428.08--1,345,429.99-
  财务费用18,761,901.38-41,795,122.03-
  投资损失-200,291.29--1,401,010.78-
  递延所得税544,441.11--15,704,014.13-
  其中:递延所得税资产减少1,097,152.76--15,170,721.67-
    递延所得税负债增加-552,711.65--533,292.46-
  存货的减少23,813,970.48--108,959,165.66-
  经营性应收项目的减少-74,433,470.07-92,671,491.6-
  经营性应付项目的增加-43,215,155.81-177,132,967.17-
  现金的期末余额751,432,502.35-770,870,272.55-
  减:现金的期初余额770,878,838.55-842,454,892.22-
  现金及现金等价物的净增加额-19,446,336.2--71,584,619.67-
公告日期2026-08-042026-04-282026-04-282025-10-24
审计意见(境内)标准无保留意见
TOP↑